Insmed INSM
$141.33 −$3.13 (-2.17%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $142.81 +1.05%
Open$143.27
Prev close$144.46
Day range$140.99 – $150.00
Volume6.22M
Market cap$31.01B
P/E (TTM)–
Dividend yield–
INSM Stock News
Headlines matching Insmed or the INSM ticker, most recent first.
- Barclays Maintains Insmed(INSM.US) With Buy Rating, Cuts Target Price to $207 Negative
- J.P. Morgan Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $175
- Goldman Sachs Maintains Insmed(INSM.US) With Buy Rating, Cuts Target Price to $188 Negative
- Mizuho Securities Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $195
- BofA Securities Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $214
- Roth MKM Maintains Insmed(INSM.US) With Buy Rating, Cuts Target Price to $198 Negative
- Morgan Stanley Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $218
- A Quick Look at Today's Ratings for Insmed(INSM.US), With a Forecast Between $170 to $237
- A Quick Look at Today's Ratings for Insmed(INSM.US), With a Forecast Between $169 to $243
- BofA Securities Maintains Insmed(INSM.US) With Buy Rating, Cuts Target Price to $209 Negative
- RBC Capital Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $195
- Mizuho Securities Maintains Insmed(INSM.US) With Buy Rating, Raises Target Price to $195 Positive
- BMO Capital Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $192
- Truist Financial Maintains Insmed(INSM.US) With Buy Rating, Announces Target Price $195
- J.P. Morgan Maintains Insmed(INSM.US) With Buy Rating, Cuts Target Price to $175 Negative
No comments yet — be the first to weigh in on INSM.
Sign in to join the discussion.